Adaptogens — Natural Protectors of the Immune System

  • Ben Tabachnik


Modern medicine tends to place an increasing emphasis on disease prevention. This involves a search for biological active substances with preventive properties. Furthermore, there is a need for specific agents to correct the disturbances of the organism’s homeostasis associated with environmental impacts and increasingly stressful lifestyles.

The field of preventive pharmacology in Russia was pioneered by the prominent Russian scientist, N. Lazarev, in the 1950–60’s. Lazarev and his colleagues were the first to study a group of plants named “Adaptogens.” Adaptogens were shown to have the ability to correct a wide range of disturbances of homeostasis and protect our immune system.

This presentation will provide an over view of studies that show the supportive effects of Adaptogens on the immune system.


USSR Academy Oral Cavity Cancer Biological Active Substance Siberian Ginseng Preventive Pharmacology 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Barenboim, G. M., Sterlina, A. G., Fisenko, A. P., et al. 1984. Studies of Natural Killer Activators with Eleutherococcus Extract. 2nd International Symposium on Eleutherococcus. All-Union Cancer Research Center, Moscow.Google Scholar
  2. 2.
    Bohn, B., Nebe, C.T., and Birr, C., “Flow-Cytometric Studies with Eleutherococcus Senticosus Extract as an Immunomodulatory Agent.” Arzneimittel-Forschung 35(10), 1987, 1193–1196.Google Scholar
  3. 3.
    Brekhman II Eleutherococcus, Nauka Publishers, Leningrad, 1968, p. 85.Google Scholar
  4. 4.
    Dardymov, IV “Some Aspects of the Mechanism of Action of Eleutherococcus Extract,” Eleutherococcus: Strategy of the Use and New Fundamental Data, Medexport, Moscow, 1984Google Scholar
  5. 5.
    Gagarin, I.A., “Eleutherococcus Prophylaxis of the Disease Incidence in the Arctic.” Adaptation and the Adaptogens. Far Eastern Scientific Center, USSR Academy of Sciences, Vladivostok.Google Scholar
  6. 6.
    Galanova, L. K., “Eleutherococcus in the Prophylaxis of Influenza and Relapses of Essential Hypertension.” Adaptation and the Adaptogens. Far Eastern Scientific Centre, USSR Academy of Sciences, Vladivostok.Google Scholar
  7. 7.
    Gvamichava, A.R., Khatiashvili, T.M., Khudzhadze, R. G., Lezhava. G. G., Tsulaya, G. E. “The first results of the use of eleutherococcus in the combined treatment of breast cancer In: Materials for Studying Ginseng and Other Medicinal Agents of the Far East.” VII. Eleutherococcus and other Adaptogens from Far Eastern Plants. Far Eastern Book Publishers. Vladivostok, 1966, p. 231–235.Google Scholar
  8. 8.
    Khatiashvili, T. M., “Experience of Liquid Eleutherococcus Extract Application in the Complex Treatment of Patients with Labial and Oral Cavity Cancer. In: Materials for Studying Ginseng and Other Therapeutic Medicines of the Far East.” 7: Eleutherococcus and Other Adaptogens Derived from Far Eastern Plants. Far Eastern Book Publishers, Vladivostok. 1966, p. 237–241.Google Scholar
  9. 9.
    Kupin, V.I., “Biologically Active Modifiers of Immunity in the Complex Treatment of Malignant New Growths.” Author’s Synopsis of the Dissertation for a Scientific Degree as a Doctor of Medical Sciences, Moscow, 1985, p. 46.Google Scholar
  10. 10.
    Kupin, V.J., Blanko, F. F., Sorokin, A. M., Comparative Evaluation of Some Biologically Active Adaptogens and the Possibility of their Application in Experimental Oncology. Paper presented at the 2nd International Symposium on Eleutherococcus, Moscow, 1984.Google Scholar
  11. 11.
    Shchezin, A. K., Zincovich, V. I., Golanova, L. K., Eleutherococcus in the Prophylaxis of Influenza, Essential Hypertension and Ischaemic Heart Disease in the Drivers of the VAP. In: New Data on Eleutherococcus and Other Adaptogens. Far Eastern Research Centre. USSR Academy of Sciences.Google Scholar
  12. 12.
    Wacker, A., Eilmes, H. G., Virushemmung mit Eleutherokokk Fluid-Extrakt. Erfahrungsheilkunde, 27(6), p. 346-51.Google Scholar
  13. 13.
    Yaremenko, K.V., Adaptogens as a Means of Prophylactic Medicine, Tomsk, 1990, p. 94.Google Scholar
  14. 14.
    Yaremenko, K.V., Pashinski, V.G., “Preparations of Natural Origin as Remedies for Prophylactic Oncology.” New Medicinal Preparations from Plants of Siberia and the Far East. Tomsk, 1986, p. 171-172.Google Scholar
  15. 15.
    Zykov, M.P., Protasova, S.F., Prospects of Immunomodulated Vaccine against Influenza Using Eleutherococcus and Other Drugs of Vegetable Origin. Paper presented at the 2nd International Symposium on Eleutherococcus. Moscow, 1984. All-Union Cancer Research Centre of the USSR Academy of Medical Sciences.Google Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Ben Tabachnik
    • 1
  1. 1.PrimeQuest InternationalMontereyUSA

Personalised recommendations